Cigna Corp. (CI) Tops Q4 EPS by 9c, Revenues Beat; Offers FY19 EPS Guidance Below Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
After-Hours Movers 1/31: (SYMC) (DGII) (CY) Higher; (CVS) (CI) (AMZN) (more...)
January 31, 2019 5:49 PM ESTToday's After-Hours Movers
Symantec (NASDAQ: SYMC) 6.3% HIGHER; reported Q3 EPS of $0.44, $0.05 better than the analyst estimate of $0.39. Revenue for the quarter came in at $1.22 billion versus the consensus estimate of $1.18 billion. Symantec sees Q4 2019 EPS of $0.37-$0.41, versus the consensus of $0.38. Symantec sees Q4 2019 revenue of $1.19-1.22 billion, versus the consensus of $1.21 billion. Symantec sees FY2019 EPS of $1.57-$1.61, versus the consensus of $1.54. Symantec sees FY2019 revenue of $4.76-4.79 billion, versus the consensus of $4.74 billion.
Trump Administration Proposes to Lower Drug Costs by Targeting Backdoor Rebates and Encouraging Direct Discounts to Patients
January 31, 2019 4:38 PM ESTOn Thursday, Health and Human Services Secretary Alex Azar and Inspector General Daniel Levinson proposed a rule to lower prescription drug prices and out-of-pocket costs by encouraging manufacturers to pass discounts directly on to patients and bringing new transparency to prescription drug markets.
Every day, Americansparticularly our seniorspay more than they need to for their prescription drugs because of a hidden system of kickbacks to middlemen. President Trump is proposing to end this era of backdoor deals in the drug industry, bring real transparency to drug markets, and deliver savings directly to patients when they walk into... More
